These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1073 related items for PubMed ID: 9512833

  • 1. Treating hypertension. Are the right drugs given to the right patients?
    Beaulieu MD, Dufresne L, LeBlanc D.
    Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
    [Abstract] [Full Text] [Related]

  • 2. [Treatment patterns of hypertension in 1996. Data from the Quebec Family Practice, University of Sherbrooke registry].
    Laplante P, Niyonsenga T, Delisle E, Vanasse N, Vanasse A, Grant AM, Xhignesse M.
    Can Fam Physician; 1998 Feb; 44():306-12. PubMed ID: 9512834
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA, Sequeira RP, Wahab AW, Mathur VS.
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive persistence and drug class.
    Marentette MA, Gerth WC, Billings DK, Zarnke KB.
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [Abstract] [Full Text] [Related]

  • 5. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program.
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [Abstract] [Full Text] [Related]

  • 6. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
    Román O, Cuevas G, Bunout D.
    Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
    [Abstract] [Full Text] [Related]

  • 7. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH.
    Med Klin (Munich); 2003 Dec 15; 98(12):771-5. PubMed ID: 14685679
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Do intensive blood pressure lowering and low-dose ASA help our hypertensive patients?
    Evans MF.
    Can Fam Physician; 1998 Dec 15; 44():2655-7. PubMed ID: 9870118
    [No Abstract] [Full Text] [Related]

  • 10. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr 15; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 11. Prescribing pattern of antihypertensive drugs in the community.
    Rotmensch HH, Mendelevitch L, Silverberg DS, Liron M.
    J Hum Hypertens; 1996 Sep 15; 10 Suppl 3():S169-72. PubMed ID: 8872853
    [Abstract] [Full Text] [Related]

  • 12. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
    Al Khaja KA, Sequeira RP.
    Pharmacoepidemiol Drug Saf; 2006 Oct 15; 15(10):741-8. PubMed ID: 16342299
    [Abstract] [Full Text] [Related]

  • 13. Contemporary practice patterns in the management of newly diagnosed hypertension.
    McAlister FA, Teo KK, Lewanczuk RZ, Wells G, Montague TJ.
    CMAJ; 1997 Jul 01; 157(1):23-30. PubMed ID: 9220938
    [Abstract] [Full Text] [Related]

  • 14. Long-term persistence with antihypertensive drugs in new patients.
    Degli Esposti E, Sturani A, Di Martino M, Falasca P, Novi MV, Baio G, Buda S, Volpe M.
    J Hum Hypertens; 2002 Jun 01; 16(6):439-44. PubMed ID: 12037702
    [Abstract] [Full Text] [Related]

  • 15. Management of hypertension. What is the role of beta blockers?
    Gifford RW.
    Postgrad Med; 1988 Feb 29; Spec No():46-9. PubMed ID: 2894661
    [Abstract] [Full Text] [Related]

  • 16. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD, Canadian Hypertension Education Program.
    Can J Cardiol; 2005 Jun 29; 21(8):657-72. PubMed ID: 16003449
    [Abstract] [Full Text] [Related]

  • 17. Impact of ALLHAT publication on antihypertensive prescribing patterns in Regione Emilia-Romagna, Italy.
    Maio V, Gagne JJ.
    J Clin Pharm Ther; 2010 Feb 29; 35(1):55-61. PubMed ID: 20175812
    [Abstract] [Full Text] [Related]

  • 18. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M, Kravzov-Jinich J, Guadarrama-Atrizco MD, Rubio-Poo C, Wertheimer AI.
    Res Social Adm Pharm; 2006 Mar 29; 2(1):22-37. PubMed ID: 17138499
    [Abstract] [Full Text] [Related]

  • 19. Factors influencing the switch in the use of antihypertensive medications.
    Chou CC, Lee MS, Ke CH, Chuang MH.
    Int J Clin Pract; 2005 Jan 29; 59(1):85-91. PubMed ID: 15707471
    [Abstract] [Full Text] [Related]

  • 20. The case for beta-blockers as first-line antihypertensive therapy.
    Cruickshank JM.
    J Hypertens Suppl; 1992 Jun 29; 10(3):S21-7. PubMed ID: 1353111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.